Aspirin for non alcoholic fatty liver disease: Promising but inconclusive-A letter to the editor

Clin Res Hepatol Gastroenterol. 2024 Mar;48(3):102286. doi: 10.1016/j.clinre.2024.102286. Epub 2024 Jan 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aspirin / therapeutic use
  • Humans
  • Liver
  • Non-alcoholic Fatty Liver Disease* / drug therapy

Substances

  • Aspirin